1. ScholarBank@NUS

Chi Lui Paul Ho

rp08450

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Chi Lui Paul Ho
Variants
Ho, P.
Ho, P.C
Ho P.C
Ho, P.C.L.
Ho, P.C.
Ho, P.C.-L.
 
Main Affiliation
 
Faculty
 
Email
phahocl@nus.edu.sg
 

Publications

Results 81-100 of 151 (Search time: 0.008 seconds).

Issue DateTitleAuthor(s)
12018Intranasal administration of carbamazepine-loaded carboxymethyl chitosan nanoparticles for drug delivery to the brainLiu, S. ; Yang, S. ; Ho, P.C. 
21-Feb-2021Investigating PEGDA and GelMA Microgel Models for Sustained 3D Heterotypic Dermal Papilla and Keratinocyte Co-CulturesTan, Justin JY; Nguyen, Duc-Viet ; Common, John E; Wu, Chunyong; Ho, Paul CL ; Kang, Lifeng 
32002Isobolographic analysis of the analgesic interactions between ketamine and tramadolChen, Y.; Chan, S.Y. ; Ho, P.C. 
42019Keratinocytes maintain compartmentalization between dermal papilla and fibroblasts in 3D heterotypic tri-culturesTan, J.J.Y.; Common, J.E.; Wu, C.; Ho, P.C.L. ; Kang, L.
5Feb-2000Kinetic study of a 2-hydroxypropyl-β-cyclodextrin-based formulation of all-trans-retinoic acid in Sprague-Dawley rats after oral or intravenous administrationLin, H.-S. ; Chan, S.Y. ; Low, K.S.Y.; Shoon, M.L.; Ho, P.C. 
6Nov-2010LC Determination of trans-3,5,3′,4′,5′- pentamethoxystilbene in rat plasmaLin, H.-S. ; Tringali, C.; Spatafora, C.; Choo, Q.-Y.; Ho, P.C. 
727-Mar-2006Limonene GP1/PG organogel as a vehicle in transdermal delivery of haloperidolLim, P.F.C. ; Liu, X.Y. ; Kang, L. ; Ho, P.C.L. ; Chan, Y.W.; Chan, S.Y. 
82009Mesoporous-silica-coated up-conversion fluorescent nanoparticles for photodynamic therapyQian, H.S. ; Guo, H.C. ; Zhang, Y. ; Ho, P.C.-L. ; Mahendran, R. 
9Oct-2010Metabolic footprinting of tumorigenic and nontumorigenic uroepithelial cells using two-dimensional gas chromatography time-of-flight mass spectrometryPasikanti, K.K.; Norasmara, J.; Cai, S.; Mahendran, R. ; Esuvaranathan, K.; Ho, P.C. ; Chan, E.C.Y. 
102020Metabolic profiling of female tg2576 mouse brains provides novel evidence supporting intranasal low-dose pioglitazone for long-term treatment at an early stage of alzheimer’s diseaseWong, L.R.; Wong, P. ; Ho, P.C.-L. 
112015Metabonomic profiling of bladder cancerChan E.C.Y ; Pasikanti K.K; Hong Y ; Ho P.C ; Mahendran R; Raman Nee Mani L; Chiong E.; Esuvaranathan K.
127-Dec-2012Metabonomic profiling of TASTPM transgenic Alzheimer's disease mouse modelHu, Z.-P.; Browne, E.R.; Liu, T.; Angel, T.E.; Ho, P.C. ; Chan, E.C.Y. 
135-Mar-2012Method development and validation for rapid quantification of hydroxychloroquine in human blood using liquid chromatography-tandem mass spectrometryWang, L.-Z. ; Ong, R.Y.-L.; Chin, T.-M. ; Thuya, W.-L. ; Wan, S.-C.; Wong, A.L.A.; Chan, S.-Y. ; Ho, P.C. ; Goh, B.-C.
1414-Feb-2012Microarray analysis revealed dysregulation of multiple genes associated with chemoresistance to As 2O 3 and increased tumor aggressiveness in a newly established arsenic-resistant ovarian cancer cell line, OVCAR-3/AsROng, P.-S. ; Chan, S.-Y. ; Ho, P.C. 
1529-Apr-2005Modeling Caco-2 permeability of drugs using immobilized artificial membrane chromatography and physicochemical descriptorsChan, E.C.Y.; Tan, W.L.; Ho, P.C. ; Fang, L.J.
16Mar-2006Monitoring of immune responses to a herbal immuno-modulator in patients with advanced colorectal cancerChen, X.; Hu, Z.-P.; Yang, X.-X.; Huang, M.; Gao, Y.; Tang, W.; Chan, S.Y. ; Dai, X.; Ye, J.; Ho, P.C.-L. ; Duan, W.; Yang, H.-Y.; Zhu, Y.-Z.; Zhou, S.-F. 
17Mar-2011Nanoparticulate delivery system targeted to tumor neovasculature for combined anticancer and antiangiogenesis therapyWang, Z.; Chui, W.-K. ; Ho, P.C. 
184-Jun-2010Noninvasive urinary metabonomic diagnosis of human bladder cancerPasikanti, K.K.; Esuvaranathan, K.; Ho, P.C. ; Mahendran, R. ; Kamaraj, R.; Wu, Q.H.; Chiong, E.; Chan, E.C.Y. 
19Feb-2003Oxide terpenes as human skin penetration enhancers of haloperidol from ethanol and propylene glycol and their modes of action on stratum corneumVaddi, H.K.; Ho, P.C.-L. ; Chan, Y.W.; Chan, S.Y. 
202006Pharmacokinetic mechanisms for reduced toxicity of irinotecan by coadministered thalidomideYang, X.-X.; Hu, Z.-P.; Chan, S.Y. ; Ho, P.C.-L. ; Boelsterli, U.A. ; Ng, K.-Y. ; Chan, E.; Chen, Y.-Z. ; Zhou, S.-F. ; Duan, W. ; Bian, J.-S. ; Huang, M.